Platelet Reactivity
Showing 26 - 50 of 4,040
ST-elevation Myocardial Infarction Trial in Caen (cangrelor perfusion during PCI, standard PCI)
Recruiting
- ST-elevation Myocardial Infarction
- cangrelor perfusion during PCI
- standard PCI
-
Caen, FranceCAEN University Hospital
Jun 23, 2021
Acute Coronary Syndrome (ACS), STEMI - ST Elevation Myocardial Infarction (MI), NSTEMI - Non-ST Segment Elevation MI Trial in
Active, not recruiting
- Acute Coronary Syndrome (ACS)
- +3 more
- CYP2C19 genotyping
-
Los Angeles, CaliforniaLAC+USC Medical Center
Sep 27, 2021
Acute Myocardial Infarction, Ticagrelor Trial in Busan (Clopidogrel 75 mg, Ticagrelor 60mg, Ticagrelor 45 mg)
Recruiting
- Acute Myocardial Infarction
- Ticagrelor
- Clopidogrel 75 mg
- +2 more
-
Busan, Korea, Republic ofDongA University Hospital
Jan 14, 2022
Acute Coronary Syndrome, Hemorrhage, Treatment Side Effects Trial in Taichung (P2Y12-reaction-units (PRU) by VerifyNow-P2Y12
Recruiting
- Acute Coronary Syndrome
- +2 more
- P2Y12-reaction-units (PRU) by VerifyNow-P2Y12 assay
-
Taichung, TaiwanFeng Yuan Hospital
Feb 25, 2021
Percutaneous Coronary Intervention Trial in Milwaukee (Ticagrelor)
Active, not recruiting
- Percutaneous Coronary Intervention
-
Milwaukee, WisconsinAurora Health Care, St. Luke's Medical Center
May 19, 2021
Platelet Aggregation, Acute Myocardial Infarction, Exercise Training Trial in Sao Paulo (Exercise Training)
Completed
- Platelet Aggregation
- +2 more
- Exercise Training
-
Sao Paulo, SP, BrazilHeart Institute of University of Sao Paulo Medical School
Mar 30, 2021
Prostacyclin Analogues in Pulmonary Arterial Hypertension
Completed
- Pulmonary Hypertension
-
Warsaw, PolandDepartment of Pulmonary Circulation, Thromboembolic Diseases and
Oct 8, 2020
Platelet Reactivity as Guidance for APT Adjustment After PCI
Completed
- PRU(Platelet Reactivity Unit)
- +2 more
- PRU(Platelet reactivity unit)
-
Taipei, TaiwanTaipei City Hospital
Nov 2, 2019
Coronary Artery Disease Trial in Nanjing (Clopidogrel, Cilostazol, Ticagrelor)
Completed
- Coronary Artery Disease
- Clopidogrel
- +2 more
-
Nanjing, Jiangsu, ChinaFirst Affiliated Hospital of Nanjing Medical University
Aug 15, 2020
Apixaban + DAPT in Lowering Platelet Reactivity and Thrombin
Completed
- Acute Coronary Syndrome
- Flow Cytrometry; Thrombin Generation Assay
-
Memphis, TennesseeCirQuest Labs, LLC
Jan 22, 2020
Individualized and Combined Effects of Smoking and Diabetes on the Antiplatelet Activity in Patients Undergoing Primary
Recruiting
- Individualized and Combined Effects of Smoking and Diabetes on the Antiplatelet Activity in Patients Undergoing Primary Percutaneous Coronary Intervention
-
Cairo, EgyptFaculty of medicine of girls, Cardiology department, Al-Azhar Un
Jun 10, 2023
Downstream Molecular Signals of P2Y12 Receptors in Hyporeactive
ST Elevation Myocardial Infarction Trial in Netherlands (Ticagrelor, Aspirin)
Recruiting
- ST Elevation Myocardial Infarction
-
Alkmaar, Netherlands
- +4 more
Aug 3, 2023
Monitoring Antiplatelet Drugs in Cardiac Arrest Patients
Recruiting
- Cardiac Arrest
- +3 more
- Antiplatelet Drug
-
Monza, MB, ItalyIRCCS San Gerardo dei Tintori
Feb 14, 2023
Ticagrelor and Aspirin in Acute Coronary Syndrome
Recruiting
- Acute Coronary Syndrome
-
Harbin, Heilongjiang, Chinathe first affiliated hospital of Harbin Medical University
Jun 9, 2022
Platelet Agregation in Patients on ECMO
Recruiting
- Platelet Refractoriness
- P2Y12 Platelet Aggregation Inhibitor
-
Ljubljana, SloveniaUMC Ljubljana
Sep 13, 2022
Critical Illness Trial in Vienna (acetylsalicylic acid, clopidogrel, prasugrel)
Unknown status
- Critical Illness
- acetylsalicylic acid
- +3 more
-
Vienna, AustriaGeneral Hospital
Aug 18, 2019
PRU, miRNA Trial in Taipei (miRNA within 24hr, miRNA after 1 week, miRNA after 1 month)
Completed
- PRU
- miRNA
- miRNA within 24hr
- +2 more
-
Taipei, TaiwanTaipei city hospital
Aug 23, 2019
Acute Coronary Syndrome Trial in Germany, Luxembourg (Blood sampling and analysis)
Terminated
- Acute Coronary Syndrome
- Blood sampling and analysis
-
Essen, Germany
- +3 more
Jan 21, 2022
Platelet Reactivity, B-amyloid, MOTS-c and Mortality of Type II
Unknown status
- Diabetes
- +3 more
-
Chaidari, Attiki, GreeceGeneral & University Hospital "Attikon"
Jul 20, 2019
Coronary Artery Disease Trial in Jacksonville (Ticagrelor 60mg, Clopidogrel)
Recruiting
- Coronary Artery Disease
- Ticagrelor 60mg
- Clopidogrel
-
Jacksonville, FloridaUniversity of Florida
Jul 6, 2022
Acute Coronary Syndrome Trial in São Paulo (Dual antiplatelet therapy: Acetylsalicylic acid + ticagrelor OR Acetylsalicylic acid
Recruiting
- Acute Coronary Syndrome
- Dual antiplatelet therapy: Acetylsalicylic acid + ticagrelor OR Acetylsalicylic acid + prasugrel
- Monotherapy: Ticagrelor alone OR Prasugrel alone
-
São Paulo, BrazilHospital Israelita Albert Einstein
Mar 2, 2023
Chronic Kidney Disease (CKD), Type 2 Diabetes (T2DM), Coronary Artery Disease (CAD) Trial in Jacksonville (Clopidogrel,
Active, not recruiting
- Chronic Kidney Disease (CKD)
- +2 more
- Clopidogrel
- Clopidogrel active metabolite
-
Jacksonville, FloridaUniversity of Florida Jacksonville
Aug 5, 2022
Coronary Artery Disease, Peripheral Vascular Disease, Myocardial Infarction Trial in Falls Church (Vorapaxar, Vorapaxar and
Completed
- Coronary Artery Disease
- +2 more
- Vorapaxar
- +3 more
-
Falls Church, VirginiaInova Fairfax Hospital
Jul 22, 2022